nf1 glutathione loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma Personalized pharmacokinetic–pharmacodynamic guided therapy via
Personalized pharmacokineticpharmacodynamic guided therapy via an induced pluripotent stem cellderived multi organoid platform in NF1 mutant breast cancer Signal Transduction and Targeted Therapy neurofibromotosis glutathione Neurofibromatosis Type 1 is a genetic disorder characterized by multiple cutaneous neurofibromas, caf au lait macules, and systemic involvement due to NF1 gene mutation. Disclaimer For educational purposes only. Not Pediatric low grade glioma models: advances and ongoing challenges Frontiers NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene
Pay in 4 interest-free payments of $7.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22


